Clinical outcomes of second‑line chemotherapy after gemcitabine and cisplatin plus S‑1 treatment for patients with advanced biliary tract cancer in the KHBO1401‑3A study-Reference-Cited by-同舟云学术

Clinical outcomes of second‑line chemotherapy after gemcitabine and cisplatin plus S‑1 treatment for patients with advanced biliary tract cancer in the KHBO1401‑3A study

Published:2023-01-11 Issue:2 Volume:49 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Shindo Yoshitaro¹,Nagano Hiroaki¹,Kanai Masashi²,Kobayashi Shogo³,Wada Hiroshi⁴,Sakai Daisuke⁵,Eguchi Hidetoshi³,Baba Hideo⁶,Kamachi Hirofumi⁷,Takayama Tadatoshi⁸,Ueno Masaki⁹,Takahashi Masahiro¹⁰,Nakagami Yuki¹,Yoshimura Kenichi¹¹,Hatano Etsuro¹²,Ioka Tatsuya¹³

Affiliation:

1. Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi 755‑8505, Japan

2. Department of Medical Oncology, Kyoto University Hospital, Kyoto 606‑8501, Japan

3. Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka 565‑0871, Japan

4. Department of Gastroenterological Surgery, Osaka International Cancer Institute, Suita, Osaka 565‑0871, Japan

5. Department of Frontier Science for Cancer and Chemotherapy, Osaka University, Suita, Osaka 565‑0871, Japan

6. Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto 860‑8556, Japan

7. Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido 060‑8648, Japan

8. Department of Digestive Surgery, Nihon University School of Medicine, Tokyo 173‑8610, Japan

9. Second Department of Surgery, School of Medicine, Wakayama Medical University, Wakayama 641‑8509, Japan

10. Department of Medical Oncology, Tohoku University Hospital, Sendai, Miyagi 980‑8574, Japan

11. Medical Center for Clinical and Translational Research, Hiroshima University Hospital, Hiroshima 734‑8551, Japan

12. Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606‑8501, Japan

13. Department of Oncology Center, Yamaguchi University Hospital, Ube, Yamaguchi 755‑8505, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Reference23 articles.

1. Essential updates to the surgical treatment of biliary tract cancer;Matsukuma;Ann Gastroenterol Surg,2019

2. Essential updates 2019/2020: Surgical treatment of gallbladder cancer;Matsuyama;Ann Gastroenterol Surg,2021

3. Current progress in systemic therapy for biliary tract cancers;Sutherland;J Hepatobiliary Pancreat Sci,2022

4. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer;Valle;N Engl J Med,2010

5. Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: The FUGA-BT (JCOG1113) randomized phase III clinical trial;Morizane;Ann Oncol,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Cost-Effectiveness of Gemcitabine and Cisplatin in Combination with S-1, Durvalumab, or Pembrolizumab as First-Line Triple Treatment for Advanced Biliary Tract Cancer;Journal of Gastrointestinal Cancer;2024-08-22

2. Exploring Molecular Mechanisms in the Second-Line Treatment of Biliary Tract Malignant Tumors;Discovery Medicine;2024

3. Real-world treatment outcomes of metastatic biliary tract cancer patients in Japan: the Tokushukai REAl-world data project 04 (TREAD 04);Japanese Journal of Clinical Oncology;2023-10-05

4. Current progress in perioperative chemotherapy for biliary tract cancer;Annals of Gastroenterological Surgery;2023-05-16